As of 2025-09-17, the Relative Valuation of Selecta Biosciences Inc (SELB) is (0.63) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -171.3%.
The range of the Relative Valuation is (1.01) - 0.67 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 16.8x - 26.4x | 21.6x |
| Fair Price | (1.01) - 0.67 | (0.63) |
| Upside | -214.6% - -24.1% | -171.3% |
| Date | P/E |